本研究的目的是展示医疗保健中的成本效益分析案例,如何在职业放射防护中考虑经济因素,同意尽可能低的合理可实现的原则,并提出瑞典立法。在本研究的第一部分,对瑞典当局和机构使用的卫生经济学中的例子进行了比较。比较的重点是统计寿命的价值,质量调整生命年,和分配给辐射防护目的的集体剂量单位的货币成本(α值)。通过这种比较,α值被确定为每个人-mSv在45美元到450美元之间的间隔,2021年瑞典社会。α值区间可以解释为:每个人mSv低于45美元是一项不错的投资。从45美元到450美元/人mSv,成本和集体剂量以外的其他因素也需要考虑。每个人mSv超过450美元太贵了。在本研究的第二部分,提供了7例职业放射防护成本效益分析。本研究特别侧重于相关因素为成本和集体剂量的情况。本案例研究表明,来自不同类型的职业放射防护的每个集体剂量的成本差异很大,在瑞典的Skaraborg医院使用。
The aim of the present study was to demonstrate cases of cost-benefit analysis within healthcare, of how economic factors can be considered in occupational radiological protection, in agreement with the as low as reasonably achievable principle and present Swedish legislations. In the first part of the present study, a comparison of examples within health economics used by authorities and institutes in Sweden was made. The comparison focused on value of a statistical life, quality-adjusted life year, and monetary cost assigned to a unit of collective dose for radiation protection purposes (α-value). By this comparison, an α-value was determined as an interval between $45 and $450 per man-mSv, for the Swedish society in 2021. The α-value interval can be interpreted as following: Less than $45 per man-mSv is a good investment. From $45 to $450 per man-mSv, other factors than costs and collective dose are important to consider. More than $450 per man-mSv is too expensive. In the second part of the present study, seven cases of cost-benefit analyses in occupational radiological protection were provided. The present study focused specifically on cases where the relevant factors were costs and collective dose. The present
case study shows a large variation in costs per collective dose from different types of occupational radiological protection, used at Skaraborg Hospital in Sweden.